Emkay says Trump midterm setback may curb sudden tariff escalation, giving India room
ANI · · AI-summarised by FinFlash
Emkay Research argues the Republican midterm defeat may reduce the risk of abrupt tariff escalation, with fewer new tools and more pressure to deliver affordability and deals before 2028. Future moves may need Section 301 or 232 investigations now that IEEPA leverage is gone. Indian goods face a 10% Section 301 duty after the proposed 18% framework rate never took effect, while Section 232 risks on pharma and electronics remain.
So What?
Lower escalation risk plus softer crude and a weaker dollar could support the rupee and Indian exporters. Section 232 action on pharma and electronics is the main remaining threat.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.